SG10201906070XA - Compositions and methods for high efficiency in vivo genome editing - Google Patents

Compositions and methods for high efficiency in vivo genome editing

Info

Publication number
SG10201906070XA
SG10201906070XA SG10201906070XA SG10201906070XA SG10201906070XA SG 10201906070X A SG10201906070X A SG 10201906070XA SG 10201906070X A SG10201906070X A SG 10201906070XA SG 10201906070X A SG10201906070X A SG 10201906070XA SG 10201906070X A SG10201906070X A SG 10201906070XA
Authority
SG
Singapore
Prior art keywords
methods
high efficiency
genome editing
compositions
vivo genome
Prior art date
Application number
SG10201906070XA
Inventor
John Verruto
Eric Moellering
Original Assignee
Synthetic Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthetic Genomics Inc filed Critical Synthetic Genomics Inc
Publication of SG10201906070XA publication Critical patent/SG10201906070XA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8213—Targeted insertion of genes into the plant genome by homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8209—Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/905—Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The present invention provides cell lines for high efficiency genome editing using cas/CRISPR systems, methods of generating such cells lines, and methods of generating mutations in the genome of an organism using such cell lines. No suitable figure
SG10201906070XA 2014-12-31 2015-12-31 Compositions and methods for high efficiency in vivo genome editing SG10201906070XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462099014P 2014-12-31 2014-12-31

Publications (1)

Publication Number Publication Date
SG10201906070XA true SG10201906070XA (en) 2019-08-27

Family

ID=56285162

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201906070XA SG10201906070XA (en) 2014-12-31 2015-12-31 Compositions and methods for high efficiency in vivo genome editing
SG11201704272YA SG11201704272YA (en) 2014-12-31 2015-12-31 Compositions and methods for high efficiency in vivo genome editing

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201704272YA SG11201704272YA (en) 2014-12-31 2015-12-31 Compositions and methods for high efficiency in vivo genome editing

Country Status (8)

Country Link
US (2) US11339399B2 (en)
EP (1) EP3240889A4 (en)
JP (2) JP2018500037A (en)
AU (1) AU2015373893B2 (en)
CA (1) CA2972454A1 (en)
IL (1) IL252970B (en)
SG (2) SG10201906070XA (en)
WO (1) WO2016109840A2 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013066438A2 (en) 2011-07-22 2013-05-10 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9340800B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College Extended DNA-sensing GRNAS
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9840699B2 (en) 2013-12-12 2017-12-12 President And Fellows Of Harvard College Methods for nucleic acid editing
US10077453B2 (en) 2014-07-30 2018-09-18 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
WO2017011707A1 (en) * 2015-07-14 2017-01-19 Synthetic Genomics, Inc Microorganisms having increased lipid productivity
JP7409773B2 (en) 2015-07-31 2024-01-09 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ Modified cells and methods of treatment
EP3344766B8 (en) * 2015-09-01 2021-03-17 Dana-Farber Cancer Institute, Inc. Systems and methods for selection of grna targeting strands for cas9 localization
CN108699116A (en) 2015-10-23 2018-10-23 哈佛大学的校长及成员们 The CAS9 albumen of evolution for gene editing
US10041079B2 (en) 2015-11-30 2018-08-07 Synthetic Genomics, Inc. Compositions and methods for expressing genes in algae
US11208649B2 (en) 2015-12-07 2021-12-28 Zymergen Inc. HTP genomic engineering platform
US9988624B2 (en) 2015-12-07 2018-06-05 Zymergen Inc. Microbial strain improvement by a HTP genomic engineering platform
WO2017100376A2 (en) 2015-12-07 2017-06-15 Zymergen, Inc. Promoters from corynebacterium glutamicum
US20170191094A1 (en) * 2015-12-31 2017-07-06 Synthetic Genomics, Inc. Expression of type i fatty acid synthase genes in eukaryotic algae
KR102345898B1 (en) 2016-06-30 2022-01-03 지머젠 인코포레이티드 Methods for generating glucose permeabilization enzyme libraries and uses thereof
KR102345899B1 (en) 2016-06-30 2021-12-31 지머젠 인코포레이티드 Methods for generating bacterial hemoglobin libraries and uses thereof
BR112019000430A2 (en) * 2016-07-13 2019-07-09 Dsm Ip Assets Bv crispr-cas system for an algae host cell
WO2018027078A1 (en) 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
EP3497214B1 (en) 2016-08-09 2023-06-28 President and Fellows of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
EP3519570B1 (en) * 2016-09-29 2022-06-08 F. Hoffmann-La Roche AG Method to analyze and optimize gene editing modules and delivery approaches
CA3039928A1 (en) 2016-10-14 2018-04-19 President And Fellows Of Harvard College Aav delivery of nucleobase editors
WO2018075664A1 (en) 2016-10-18 2018-04-26 Regents Of The University Of Minnesota Tumor infiltrating lymphocytes and methods of therapy
GB201618414D0 (en) * 2016-11-01 2016-12-14 Patterson James Regulated cell lines and methods of use thereof
GB201618507D0 (en) * 2016-11-02 2016-12-14 Stichting Voor De Technische Wetenschappen And Wageningen Univ Microbial genome editing
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
WO2018165504A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Suppression of pain by gene editing
EP3592777A1 (en) 2017-03-10 2020-01-15 President and Fellows of Harvard College Cytosine to guanine base editor
US11268082B2 (en) 2017-03-23 2022-03-08 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable DNA binding proteins
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
WO2018220582A1 (en) * 2017-05-31 2018-12-06 Tropic Biosciences UK Limited Methods of selecting cells comprising genome editing events
EP3645021A4 (en) 2017-06-30 2021-04-21 Intima Bioscience, Inc. Adeno-associated viral vectors for gene therapy
JP2020534795A (en) 2017-07-28 2020-12-03 プレジデント アンド フェローズ オブ ハーバード カレッジ Methods and Compositions for Evolving Base Editing Factors Using Phage-Supported Continuous Evolution (PACE)
US11319532B2 (en) 2017-08-30 2022-05-03 President And Fellows Of Harvard College High efficiency base editors comprising Gam
US11795443B2 (en) 2017-10-16 2023-10-24 The Broad Institute, Inc. Uses of adenosine base editors
WO2019113463A1 (en) 2017-12-08 2019-06-13 Synthetic Genomics, Inc. Improving algal lipid productivity via genetic modification of a tpr domain containing protein
CA3084828A1 (en) * 2017-12-29 2019-07-04 Synthetic Genomics, Inc. Genetic modulation of photosynthetic organisms for improved growth
KR20210045360A (en) * 2018-05-16 2021-04-26 신테고 코포레이션 Methods and systems for guide RNA design and use
WO2020023353A1 (en) * 2018-07-23 2020-01-30 Synthetic Genomics, Inc. Microorganisms having increased lipid production, and compositions and methods of making and using the same
EP3862430A4 (en) * 2018-10-04 2022-06-15 Kaneka Corporation Dna construct to be used in genome editing of plant
KR20210091167A (en) * 2018-10-16 2021-07-21 블루알렐, 엘엘씨 Methods for targeted insertion of DNA in genes
US11162106B2 (en) * 2018-12-19 2021-11-02 Synthetic Genomics, Inc. Inducible expression of genes in algae
WO2020191243A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
KR20210148269A (en) * 2019-04-05 2021-12-07 다니스코 유에스 인크. Methods for integrating donor DNA sequences into the Bacillus genome using linear recombinant DNA constructs and compositions thereof
CN110331169A (en) * 2019-07-05 2019-10-15 亢庆铮 It is a kind of efficiently quickly in screening-gene regulatory region functional site method and application
JP7428459B2 (en) * 2019-07-08 2024-02-06 株式会社ユーグレナ Euglena genome modification method and Euglena breeding method
WO2021085580A1 (en) * 2019-10-31 2021-05-06 国立研究開発法人理化学研究所 Polynucleotide and use for same
DE112021002672T5 (en) 2020-05-08 2023-04-13 President And Fellows Of Harvard College METHODS AND COMPOSITIONS FOR EDIT BOTH STRANDS SIMULTANEOUSLY OF A DOUBLE STRANDED NUCLEOTIDE TARGET SEQUENCE
WO2022080234A1 (en) * 2020-10-12 2022-04-21 Dic株式会社 Method for modifying genome of algae belonging to genus galdieria
WO2023147058A2 (en) * 2022-01-27 2023-08-03 Asklepios Biopharmaceutical, Inc. Compositions for treating neurological disease
WO2023225358A1 (en) * 2022-05-20 2023-11-23 The Board Of Trustees Of The Leland Stanford Junior University Generation and tracking of cells with precise edits

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304200D0 (en) 1993-03-02 1993-04-21 Sandoz Ltd Improvements in or relating to organic compounds
US5767373A (en) 1994-06-16 1998-06-16 Novartis Finance Corporation Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
US8119859B2 (en) 2008-06-06 2012-02-21 Aurora Algae, Inc. Transformation of algal cells
MX2013015327A (en) 2011-06-30 2014-01-31 Exxonmobil Res & Eng Co Regulation of toxin and antitoxin genes for biological containment.
US8709766B2 (en) 2011-10-17 2014-04-29 Colorado School Of Mines Use of endogenous promoters in genetic engineering of Nannochloropsis gaditana
US8809026B2 (en) 2011-12-27 2014-08-19 Commonwealth Scientific And Industrial Research Organisation Processes for producing lipids
US9637739B2 (en) 2012-03-20 2017-05-02 Vilnius University RNA-directed DNA cleavage by the Cas9-crRNA complex
GB2537000C (en) * 2012-05-25 2019-10-09 Univ California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10612034B2 (en) 2012-06-01 2020-04-07 Exxonmobil Research And Engineering Company Promoters and terminators for use in eukaryotic cells
US9546372B2 (en) 2012-06-12 2017-01-17 Synthetic Genomics, Inc. Regulatory elements and uses thereof
AU2012396282B2 (en) 2012-12-04 2016-05-19 Exxonmobil Research And Engineering Company Tetraselmis promoters and terminators for use in eukaryotic cells
US9982272B2 (en) 2012-12-06 2018-05-29 Synthetic Genomics, Inc. Algal mutants having a locked-in high light acclimated phenotype
WO2014093701A1 (en) * 2012-12-12 2014-06-19 The Broad Institute, Inc. Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
CN105164264B (en) 2012-12-12 2021-05-07 布罗德研究所有限公司 Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications
EP4234696A3 (en) 2012-12-12 2023-09-06 The Broad Institute Inc. Crispr-cas component systems, methods and compositions for sequence manipulation
DK2921557T3 (en) 2012-12-12 2016-11-07 Broad Inst Inc Design of systems, methods and optimized sequence manipulation guide compositions
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
CN114230675A (en) * 2013-06-05 2022-03-25 杜克大学 RNA-guided gene editing and gene regulation
JP6625971B2 (en) * 2013-06-17 2019-12-25 ザ・ブロード・インスティテュート・インコーポレイテッド Delivery, engineering and optimization of tandem guide systems, methods and compositions for array manipulation
US9765126B2 (en) 2013-10-04 2017-09-19 Synthetic Genomics, Inc. Compositions and methods for modulating biomass productivity
WO2015103307A1 (en) 2013-12-31 2015-07-09 Synthetic Genomics, Inc. Biomass productivity regulator
CN103668472B (en) * 2013-12-31 2014-12-24 北京大学 Method for constructing eukaryon gene knockout library by using CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 system
JP7057786B2 (en) * 2016-12-30 2022-04-20 シンセティック ジェノミクス インコーポレーテッド Highly productive algal mutants with reduced photosynthetic antennas

Also Published As

Publication number Publication date
US20210017530A1 (en) 2021-01-21
CA2972454A1 (en) 2016-07-07
US20170073695A1 (en) 2017-03-16
SG11201704272YA (en) 2017-06-29
EP3240889A2 (en) 2017-11-08
EP3240889A4 (en) 2018-06-20
JP2018500037A (en) 2018-01-11
WO2016109840A3 (en) 2016-10-13
JP7046139B2 (en) 2022-04-01
JP2021036866A (en) 2021-03-11
IL252970B (en) 2021-07-29
WO2016109840A9 (en) 2016-11-17
AU2015373893A1 (en) 2017-06-15
IL252970A0 (en) 2017-08-31
WO2016109840A2 (en) 2016-07-07
AU2015373893B2 (en) 2021-07-29
US11339399B2 (en) 2022-05-24

Similar Documents

Publication Publication Date Title
SG10201906070XA (en) Compositions and methods for high efficiency in vivo genome editing
MX2019003616A (en) SC-ß CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME.
SG10201810150UA (en) Compositions and methods for enhanced gene expression in cone cells
IL251576A0 (en) Methods and compositions for generating or maintaining pluripotent cells
GB2557123A (en) Modified cells and methods of therapy
WO2016057821A3 (en) Therapeutic uses of genome editing with crispr/cas systems
MX2019011040A (en) Compositions and methods for enhanced gene expression.
EP4275747A3 (en) Therapeutic applications of cpf1-based genome editing
WO2014144761A3 (en) Increasing specificity for rna-guided genome editing
MX2020004608A (en) Methods, compositions and components for crispr-cas9 editing of tgfbr2 in t cells for immunotherapy.
SG10201906513WA (en) Crispr hybrid dna/rna polynucleotides and methods of use
MX2020000621A (en) Methods and compositions for immunomodulation.
EP3800248A3 (en) Crispr-cas-related methods, compositions and components for cancer immunotherapy
SG10201810723VA (en) Improved t cell compositions
MY191581A (en) Anti-pd-1 antibodies
UA118380C2 (en) Substituted dihydroisoquinolinone compounds
MY192824A (en) Compound targeting il-23a and tnf-alpha and uses thereof
MY193650A (en) Extracellular matrix compositions
MX2018003678A (en) Molecular quality assurance methods for use in sequencing.
EP3230987B8 (en) Apparatus for the generation, distribution and/or usage of electrical energy and component for such an apparatus
AU2015315168A8 (en) Targeted mutagenesis in spirulina
EP3307873A4 (en) Hematopoietic cells and methods of using and generating the same
MX2021008225A (en) Compositions and methods for treatment of abnormal cell growth.
MX2018012872A (en) Compositions and methods for enhanced gene expression of pklr.
MX2018016322A (en) Hydrolysis stable compositions for films in solar cells.